ALLEN ROBERT D. III (Chief Scientific Officer) sold 24.7% of their position (37.58K shares) of INVIVYD, INC. on the open market
Open‑market sale worth $58.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/18/2026ACC: 0001193125-26-057828
Officer· Chief Scientific Officer
Since Feb 2026
-37.58K
Net shares
Net seller
$58.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
99K acquired · 136.58K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+99K
Price / share
—
Trade value
—
% of position
186.6%
2/15/2026
53.07K→152.07K
Common Stock
Direct
Shares
−18.19K
Price / share
$1.54
Trade value
$28K
% of position
12.0%
2/17/2026
152.07K→133.88K
Common Stock
Direct
Shares
−19.39K
Price / share
$1.58
Trade value
$30.60K
% of position
14.5%
2/18/2026
133.88K→114.49K
Total
Net shares
+61.42K
Net value
-$58.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2026 | M · Option Exercise | +99K | — | — | 186.6% | 53.07K | 152.07K |
| Common Stock Direct | 2/17/2026 | S · Sale | −18.19K | $1.54 | $28K | 12.0% | 152.07K | 133.88K |
| Common Stock Direct | 2/18/2026 | S · Sale | −19.39K | $1.58 | $30.60K | 14.5% | 133.88K | 114.49K |
| Total | +61.42K | -$58.60K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
99K shares
Shares
−99K
Strike price
Held after
102K
Exercisable
—
2/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock99K shares | 2/15/2026 | M · Option Exercise | −99K | — | 102K |